CD8A and neoplasm: We found that there was indeed no effect on both E7-specific CD8 + T cells (Fig. 4C) and tumor complete remission (CR) after CCR3 + cell depletion in XCL1-E6E7 treated mice bearing TC-1 tumors (3/7 vs 4/7 CR, Fig. 4D).